The last stage of small intestine cancer is stage IV or metastatic. The cancer has spread beyond the small intestine to other body parts at this stage. It is important to note that small intestine cancer accounts for less than 1% of all gastrointestinal cancers. However, it can be pretty aggressive and challenging to treat when it does occur.
In stage IV small intestine cancer, the cancer cells have typically spread to nearby lymph nodes and may have metastasised to distant organs such as the liver, lungs, or bones. The exact locations of metastasis can vary depending on the individual case. This spread of cancer cells to other parts of the body makes treatment more challenging and can significantly impact the patient’s prognosis.
Stage IV small intestine cancer symptoms may include abdominal pain, weight loss, fatigue, and changes in bowel habits. However, it is essential to note that symptoms can vary widely and may not always be specific to small intestine cancer. Therefore, consulting a medical professional for an accurate diagnosis and treatment plan is crucial.
The treatment options for stage IV small intestine cancer typically involve a multidisciplinary approach. They aim to manage symptoms, slow the disease’s progression, and improve the patient’s quality of life. Surgery may be considered in some cases to remove tumours or relieve obstruction caused by cancer. However, surgery may not always be feasible due to the advanced stage of the disease.
Chemotherapy is often used as a primary treatment for stage IV small intestine cancer. It involves using drugs to kill or slow the growth of the cancer cells. The specific chemotherapy regimen may vary depending on the individual case. It may be given before or after surgery or sometimes as the main treatment for patients who are not surgical candidates.
Targeted therapy is another treatment method that may be considered for stage IV small intestine cancer. This type of therapy targets specific molecules or the pathways involved in the growth or spread of cancer cells. It is used in a combination with chemotherapy or as a standalone treatment. The choice of targeted therapy will depend on the tumour’s characteristics and the individual’s overall health.
Immunotherapy is an emerging treatment option that is being studied for small intestine cancer. It involves using drugs that enhance the body’s immune system and attack the recognised cancer cells. While still in the early stages of research, immunotherapy has shown promising results in other types of cancer and may be beneficial for small intestine cancer.
In addition to all the available medical treatments, supportive care is essential to managing stage IV small intestine cancer. This may involve pain management, nutritional support, and psychological support to help patients cope with the physical and emotional challenges of the disease. It is important to note that the prognosis for stage IV small intestine cancer is generally low, with a five-year survival rate of around 15%.
The last stage of small intestine cancer is stage IV or metastatic. The cancer has spread beyond the small intestine to other body parts at this stage. Treatment options for stage IV small intestine cancer typically involve a multidisciplinary approach, including surgery, chemotherapy, targeted therapy, and supportive care. While the prognosis for stage IV small intestine cancer is generally poor, patients must consult their doctor to explore the available treatment options and make informed decisions about their care.
